This compound is primarily utilized in the pharmaceutical and research sectors due to its potential biological activity. It is often investigated for its role in the development of therapeutic agents, particularly in the treatment of neurological disorders. The presence of the piperazine and aniline moieties makes it a promising candidate for modulating receptors in the central nervous system, which could lead to applications in antipsychotic or antidepressant medications. Additionally, its structure suggests potential use in the synthesis of compounds targeting specific enzymes or proteins involved in disease pathways. Researchers also explore its derivatives for their pharmacological properties, aiming to optimize efficacy and reduce side effects in drug development.